Phase 2 Randomized, Open-Label, Multicenter Study To Evaluate The Efficacy And Safety Of Plamotamab Combined With Tafasitamab (Tafa) + Lenalidomide (Len) Vs Tafa+Len In Relapsed Or Refractory Dlbcl
Lenalidomide;Plamotamab;Tafasitamab;Lenalidomide;Tafasitamab
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: Phase 2 Randomized, Open-Label, Multicenter Study To Evaluate The Efficacy And Safety Of Plamotamab Combined With Tafasitamab (Tafa) + Lenalidomide (Len) Vs Tafa+Len In Relapsed Or Refractory Dlbcl ### Output: Lenalidomide;Plamotamab;Tafasitamab;Lenalidomide;Tafasitamab